ObsEva SA (OBSEF)

Market Cap	11.72K
Revenue (ttm)	19.64M -11.5%
Net Income	7.92M
EPS	0.07
Shares Out	117.18M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,725
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	20.16
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ObsEva

ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: OBSEF

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 20, 2026

Data Sources Report a data error